Format

Send to

Choose Destination
Inflammation. 2017 Feb;40(1):295-302. doi: 10.1007/s10753-016-0437-9.

Recent Advances in Aptamers Targeting Immune System.

Hu PP1,2.

Author information

1
Department of Gastroenterology, The First Affiliated Hospital, Nanchang University, Nanchang, Jiangxi, 330006, China. piaoping_81@163.com.
2
Department of Blood Transfusion, The First Affiliated Hospital, Nanchang University, Nanchang, Jiangxi, 330006, China. piaoping_81@163.com.

Abstract

The immune system plays important role in protecting the organism by recognizing non-self molecules from pathogen such as bacteria, parasitic worms, and viruses. When the balance of the host defense system is disturbed, immunodeficiency, autoimmunity, and inflammation occur. Nucleic acid aptamers are short single-stranded DNA (ssDNA) or RNA ligands that interact with complementary molecules with high specificity and affinity. Aptamers that target the molecules involved in immune system to modulate their function have great potential to be explored as new diagnostic and therapeutic agents for immune disorders. This review summarizes recent advances in the development of aptamers targeting immune system. The selection of aptamers with superior chemical and biological characteristics will facilitate their application in the diagnosis and treatment of immune disorders.

KEYWORDS:

aptamer; immune system; inflammation; therapy

PMID:
27590235
DOI:
10.1007/s10753-016-0437-9
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center